IP Library Granted Patent US 6,864,233
Granted Patent B2
US 6,864,233 · App. 10/220,829 · Granted Mar 8, 2005

Fungicidal echinocandin derivatives and their preparation

Assignee: Aventis Pharma S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,864,233
App. No.
10/220,829
Granted
Mar 8, 2005
Kind
B2
Abstract

The invention concerns compounds of general formula (I) wherein: R 1 represents a hydrogen atom, a hydroxy radical, Ob or Ncd; A represents an oxygen atom, a CH 2 radical or a NH radical; B represents the radical of a steroid; R 3 represents a hydrogen atom, a methyl or hydroxyl radical; R 4 represents a hydrogen atom or a hydroxyl radical; T represents a hydrogen atom, a methyl radical, a CH 1 CONH 2 , CH 2 C≡N radical, a (CH 2 ) 2 NH 2 or (CH 2 )2Nalk + X − radical; X being a halogen atom and alc an alkyl radical; Y represents a hydrogen atom, a hydroxyl radical or a halogen atom or a OSO 3 H radical; W represents a hydrogen atom or a OH radical; Z represents a hydrogen atom or a methyl radical. The compounds of formula (I) exhibit antifungal properties.

Claims (33)

1. A compound of the formula:

wherein R 1 is selected from the group consisting of hydrogen, hydroxyl, Ob

b is selected from the group consisting of alkyl, alkenyl and alkynyl of up to 12 carbon atoms, optionally substituted by halogen;

b′ and b″ are individually selected from the group consisting of hydrogen, alkyl of up to 12 carbon atoms and unsubstituted or substituted aryl;

c and d are selected from the group consisting of hydrogen, alkyl and cycloalkyl of up to 8 carbon atoms, optionally interrupted by an oxygen atom and unsubstituted or substituted by a member selected from the group consisting of halogen, OH and

c 1 and d 1 are hydrogen or alkyl of up to 8 carbon atoms or c 1 and d 1 form with the nitrogen atom a heterocycle optionally containing at least one heteroatom,

A is selected from the group consisting of oxygen, —CH 2 — and NH,

B is a steroid linked at position 3,

R 3 is selected from the group consisting of hydrogen, methyl and hydroxyl,

R 4 is hydrogen or hydroxyl,

T is selected from the group consisting of hydrogen, methyl, —CH 2 —CONH 2 ),

—CH 2 ≡N, —(CH 2 ) 2 NH 2 and —(CH 2 ) 2 Alk + X, X is halogen and Alk is an alkyl of up to 8 carbon atoms,

Y is selected from the group consisting of hydrogen, hydroxyl, halogen and —OSO 2 H or a salt thereof,

W is hydrogen or —OH,

Z is hydrogen or methyl and its pharmaceutically acceptable acid addition salts.

2. The compound of claim 1 wherein T is hydrogen.

3. The compound of claim 1 wherein Y is hydrogen.

4. The compound of claim 1 wherein Z is methyl.

5. The compound of claim 1 wherein R 3 is methyl.

6. The compound of claim 1 wherein R 4 is hydroxyl.

7. The compound of claim 1 wherein R 1 is hydroxyl.

8. The compound of claim 1 wherein A is oxygen.

9. The compound of claim 1 wherein A is —CH 2 —.

10. The compound of claim 1 wherein B is selected from the group consisting of:

11. The compound of claim 10 wherein B is :

12. A compound of claim 1 selected from the group consisting of:

1-[(4R,5-dihydroxy-N2-[[[(3β22E)-ergosta-5,7,22-trien-3-yl]oxy]carbony]-L-ornithinel]-mulundocandin,

1-[(4R,5R)-4,5-dihydroxy-N2-[[[3β-lanosta-8,24-dien-3-yl]-L-ornithine]-deoxymulundocandin and

1-[(4R,5R)-4,5-dihyddroxy-N2-[[[(3β,22E)-ergosta-5,7,22-trien-3-yl]oxy]carbonyl]-L-ornithine]-deoxymulundocandin.

13. A process for the preparation of a compound of claim 1 comprising reacting a compound of the formula:

with a steroid BOH where B is defined as in claim 1 or of one of its derivatives in the presence of an activator of the alcohol function, or of a corresponding acid or of one of its derivatives, to obtain the corresponding compound of formula (I).

14. An antifungal composition comprising an antifungicidally effective amount of a compound of claim 1 and an inert carrier.

15. A method of treating fungal infections in warm-blooded animals comprising administering to warm-blooded animals in need thereof an antifungicidally effective amount of a compound of claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2006
From: AVENTIS PHARMA S.A.
To: NOVEXEL
Reel/Frame 018545/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2002
From: COURTIN, OLIVIER; DUSSAPAT, ARLETTE; MANGUER, DOMINIQUE MELON; SCHIO, LAURENT
To: AVENTIS PHARMA S.A.
Reel/Frame 014364/0393 →
Priority Claims (1)
FR 00 01844 · Feb 15, 2000 · national
Continuity (1)
Related Publication 20040014602A1 · Jan 22, 2004